Here are three more details the drugmaker revealed Nov. 2 in its third-quarter earnings report.
- Pfizer’s third-quarter sales revenue totaled $24.1 billion, primarily driven by sales of the drugmaker’s COVID-19 vaccine.
- Revenue from sales of Pfizer’s COVID-19 vaccine totaled $13 billion in the third quarter.
- More than 75 percent of the vaccine’s sales in 2021 are from outside the U.S.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
